Treatment of LSCD With DM

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Limbal Stem-cell DeficiencyCongenital Aniridia
Interventions
PROCEDURE

transplantation of a Descemet's Membrane corneal onlay, partial LSCD

The worst seeing eye of these patients (or a randomized eye if vision is equal bilaterally) will be treated with superficial keratectomy to remove any pannus and debride the central corneal epithelium, followed by transplantation of a Descemet's membrane corneal onlay. Patient will be followed for 6 months and evaluated for improvement in visual acuity and improvement in limbal stem cell deficiency, and monitored for adverse events.

PROCEDURE

transplantation of a Descemet's Membrane corneal onlay, total/near-total LSCD

The worst seeing eye of these patients (or a randomized eye if vision is equal bilaterally) will be treated with superficial keratectomy to remove any pannus and debride the central corneal epithelium, followed by transplantation of a Descemet's membrane (DM) corneal onlay. Patient will be followed for 6 months and evaluated for improvement in visual acuity, limbal stem cell deficiency, and persistent epithelial defects/recurrent erosions, and monitored for adverse events.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT05909735 - Treatment of LSCD With DM | Biotech Hunter | Biotech Hunter